Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chagas disease 101.

Literature DB >> 20571553

Chagas disease 101.

Julie Clayton.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2010 PMID： 20571553 DOI： 10.1038/nature09220

Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 49.962

× No keyword cloud information.

4 in total

1. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy.

Authors: E M Jones; D G Colley; S Tostes; E R Lopes; C L Vnencak-Jones; T L McCurley
Journal: Am J Trop Med Hyg Date: 1993-03 Impact factor: 2.345

2. Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela.

Authors: Belkisyolé Alarcón de Noya; Zoraida Díaz-Bello; Cecilia Colmenares; Raiza Ruiz-Guevara; Luciano Mauriello; Reinaldo Zavala-Jaspe; José Antonio Suarez; Teresa Abate; Laura Naranjo; Manuel Paiva; Lavinia Rivas; Julio Castro; Juan Márques; Iván Mendoza; Harry Acquatella; Jaime Torres; Oscar Noya
Journal: J Infect Dis Date: 2010-05-01 Impact factor: 5.226

3. Control of Chagas disease.

Authors:
Journal: World Health Organ Tech Rep Ser Date: 2002

4. Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic chagas heart disease.

Authors: Alejandro G Schijman; Carlos A Vigliano; Rodolfo J Viotti; Juan M Burgos; Silvia Brandariz; Bruno E Lococo; Maria I Leze; Hector A Armenti; Mariano J Levin
Journal: Am J Trop Med Hyg Date: 2004-02 Impact factor: 2.345

4 in total

51 in total

1. Preponderance of inhibitory versus excitatory intramuscular nerve fibres in human chagasic megacolon.

Authors: Samir Jabari; Alexandre B M da Silveira; Enio C de Oliveira; Karl Quint; Winfried Neuhuber; Axel Brehmer
Journal: Int J Colorectal Dis Date: 2012-06-23 Impact factor: 2.571

2. Evidence of ternary complex formation in Trypanosoma cruzi trans-sialidase catalysis.

Authors: Isadora A Oliveira; Arlan S Gonçalves; Jorge L Neves; Mark von Itzstein; Adriane R Todeschini
Journal: J Biol Chem Date: 2013-11-05 Impact factor: 5.157

3. Clinical reasoning: a 32-year-old woman with right-sided numbness and word-finding difficulties.

Authors: Ania Busza; Anna M Cervantes-Arslanian; Carlos S Kase
Journal: Neurology Date: 2014-08-26 Impact factor: 9.910

4. The detection of Trypanosoma cruzi by nested-PCR in elderly patients: relationship to the clinical and epidemiological profile.

Authors: Mariane Barroso Pereira; Angélica Martins Batista; Camila Aguiar; Glaucia Elisete Barbosa Marcon; Luiz Cláudio Martins; Maria Elena Guariento; Sandra Cecília Botelho Costa; Eros Antonio de Almeida
Journal: Pathog Glob Health Date: 2016-09-26 Impact factor: 2.894

5. Trypanosoma cruzi Calreticulin Topographical Variations in Parasites Infecting Murine Macrophages.

Authors: Andrea González; Carolina Valck; Gittith Sánchez; Steffen Härtel; Jorge Mansilla; Galia Ramírez; María Soledad Fernández; José Luis Arias; Norbel Galanti; Arturo Ferreira
Journal: Am J Trop Med Hyg Date: 2015-03-09 Impact factor: 2.345

6. Molecular modeling study on the disassembly of dendrimers designed as potential antichagasic and antileishmanial prodrugs.

Authors: Jeanine Giarolla; Kerly F M Pasqualoto; Daniela G Rando; Márcio H Zaim; Elizabeth I Ferreira
Journal: J Mol Model Date: 2011-10-02 Impact factor: 1.810

7. Diversity-oriented synthesis yields a new drug lead for treatment of chagas disease.

Authors: Sivaraman Dandapani; Andrew R Germain; Ivan Jewett; Sebastian le Quement; Jean-Charles Marie; Giovanni Muncipinto; Jeremy R Duvall; Leigh C Carmody; Jose R Perez; Juan C Engel; Jiri Gut; Danielle Kellar; Jair Lage Siqueira-Neto; James H McKerrow; Marcel Kaiser; Ana Rodriguez; Michelle A Palmer; Michael Foley; Stuart L Schreiber; Benito Munoz
Journal: ACS Med Chem Lett Date: 2013-12-29 Impact factor: 4.345

8. Organocatalytic, enantioselective synthesis of VNI: a robust therapeutic development platform for Chagas, a neglected tropical disease.

Authors: Mark C Dobish; Fernando Villalta; Michael R Waterman; Galina I Lepesheva; Jeffrey N Johnston
Journal: Org Lett Date: 2012-12-07 Impact factor: 6.005

9. Molecular imaging, biodistribution and efficacy of mesenchymal bone marrow cell therapy in a mouse model of Chagas disease.

Authors: Antonio C Campos de Carvalho; David C Spray; Linda A Jelicks; Herbert B Tanowitz; Vera Maria Peters; Rosalia Mendez-Otero
Journal: Microbes Infect Date: 2014-09-16 Impact factor: 2.700

10. In vitro and in vivo studies of the biological activity of novel arylimidamides against Trypanosoma cruzi.

Authors: J S De Araújo; C F Da Silva; D G J Batista; P B Da Silva; M B Meuser; C A F Aiub; M F V da Silva; C F Araújo-Lima; M Banerjee; A A Farahat; C E Stephens; A Kumar; D W Boykin; M N C Soeiro
Journal: Antimicrob Agents Chemother Date: 2014-03-03 Impact factor: 5.191